Vaccine Makers Pause R&D and Trim Jobs as Policy Climate Shifts

Moderna is pulling back on late-stage vaccine studies, while other vaccine developers pause projects and cut positions amid a chilling policy environment under health secretary RFK Jr. The trend is illustrated by Moderna pausing trials in Massachusetts, a Texas factory project being canceled, and layoffs at a San Diego manufacturer, signaling a broader slowdown in vaccine development and manufacturing.